BIOMAT Database Logo BIOMAT Database Logo

The role of histone demethylases in cancer therapy. 2012

Inga Hoffmann, and Martin Roatsch, and Martin L Schmitt, and Luca Carlino, and Martin Pippel, and Wolfgang Sippl, and Manfred Jung
Institute of Pharmaceutical Sciences, Albert-Ludwigs-University of Freiburg, Albertstr. 25, 79104 Freiburg, Germany.

Reversible histone methylation has emerged in the last few years as an important mechanism of epigenetic regulation. Histone methyltransferases and demethylases have been identified as contributing factors in the development of several diseases, especially cancer. Therefore, they have been postulated to be new drug targets with high therapeutic potential. Here, we review histone demethylases with a special focus on their potential role in oncology drug discovery. We present an overview over the different classes of enzymes, their biochemistry, selected data on their role in physiology and already available inhibitors.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006657 Histones Small chromosomal proteins (approx 12-20 kD) possessing an open, unfolded structure and attached to the DNA in cell nuclei by ionic linkages. Classification into the various types (designated histone I, histone II, etc.) is based on the relative amounts of arginine and lysine in each. Histone,Histone H1,Histone H1(s),Histone H2a,Histone H2b,Histone H3,Histone H3.3,Histone H4,Histone H5,Histone H7
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D044127 Epigenesis, Genetic A genetic process by which the adult organism is realized via mechanisms that lead to the restriction in the possible fates of cells, eventually leading to their differentiated state. Mechanisms involved cause heritable changes to cells without changes to DNA sequence such as DNA METHYLATION; HISTONE modification; DNA REPLICATION TIMING; NUCLEOSOME positioning; and heterochromatization which result in selective gene expression or repression. Epigenetic Processes,Epigenetic Process,Epigenetics Processes,Genetic Epigenesis,Process, Epigenetic,Processes, Epigenetic,Processes, Epigenetics
D055808 Drug Discovery The process of finding chemicals for potential therapeutic use. Drug Prospecting,Discovery, Drug,Prospecting, Drug

Related Publications

Inga Hoffmann, and Martin Roatsch, and Martin L Schmitt, and Luca Carlino, and Martin Pippel, and Wolfgang Sippl, and Manfred Jung
Targeting histone demethylases in cancer therapy.
December 2009, Clinical cancer research : an official journal of the American Association for Cancer Research,
Inga Hoffmann, and Martin Roatsch, and Martin L Schmitt, and Luca Carlino, and Martin Pippel, and Wolfgang Sippl, and Manfred Jung
Prominent role of histone lysine demethylases in cancer epigenetics and therapy.
September 2018, Oncotarget,
Inga Hoffmann, and Martin Roatsch, and Martin L Schmitt, and Luca Carlino, and Martin Pippel, and Wolfgang Sippl, and Manfred Jung
The emerging role of histone lysine demethylases in prostate cancer.
August 2012, Molecular cancer,
Inga Hoffmann, and Martin Roatsch, and Martin L Schmitt, and Luca Carlino, and Martin Pippel, and Wolfgang Sippl, and Manfred Jung
Histone demethylases and cancer.
January 2009, Advances in cancer research,
Inga Hoffmann, and Martin Roatsch, and Martin L Schmitt, and Luca Carlino, and Martin Pippel, and Wolfgang Sippl, and Manfred Jung
Histone Demethylases in Colon Cancer.
December 2014, Current colorectal cancer reports,
Inga Hoffmann, and Martin Roatsch, and Martin L Schmitt, and Luca Carlino, and Martin Pippel, and Wolfgang Sippl, and Manfred Jung
Targeting histone demethylases as a potential cancer therapy (Review).
September 2022, International journal of oncology,
Inga Hoffmann, and Martin Roatsch, and Martin L Schmitt, and Luca Carlino, and Martin Pippel, and Wolfgang Sippl, and Manfred Jung
Histone lysine demethylases in breast cancer.
May 2013, Critical reviews in oncology/hematology,
Inga Hoffmann, and Martin Roatsch, and Martin L Schmitt, and Luca Carlino, and Martin Pippel, and Wolfgang Sippl, and Manfred Jung
Role of histone demethylases and histone methyltransferases in triple-negative breast cancer: Epigenetic mnemonics.
March 2022, Life sciences,
Inga Hoffmann, and Martin Roatsch, and Martin L Schmitt, and Luca Carlino, and Martin Pippel, and Wolfgang Sippl, and Manfred Jung
The role of histone H3 lysine demethylases in glioblastoma.
June 2023, Cancer metastasis reviews,
Inga Hoffmann, and Martin Roatsch, and Martin L Schmitt, and Luca Carlino, and Martin Pippel, and Wolfgang Sippl, and Manfred Jung
Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy.
January 2016, Clinical epigenetics,
Copied contents to your clipboard!